The letter, addressed to Senate Health, Education, Labor and Pensions Committee (HELP) chair Bill Cassidy, R-IL, is written and supported by 207 biotech innovators, including industry heavyweights ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.